Innovative HIV drugs

Biopharmaceutical companies are working aggressively on improving treatment regimens, preventive vaccines and more effective therapies that are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).

  • A first-in-class medicine helps to prevent HIV from breaking through the plasma membrane
  • A cell therapy that helps to modify a patient’s own cells in an attempt to make them resistant to HIV.
  • A therapeutic vaccine designed to bring on responses from T cells which play a role in immune protection against viral infections